Raphael Pharmaceutical Inc. SEC filings RAPH
Raphael Pharmaceutical Inc. has 179 filings in SEC EDGAR's recent list, going back to Oct 24, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Apr 6, 2026 | Nov 20, 2025 |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | May 12, 2022 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 2, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 5, 2025 |
| 3 | Initial insider ownership | Feb 13, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Mar 25, 2024 | Nov 25, 2023 |
| 4 | Insider transaction | Mar 25, 2024 | Aug 29, 2023 |
| 4 | Insider transaction | Mar 13, 2023 | Dec 5, 2022 |
| 4 | Insider transaction | Mar 13, 2023 | Dec 5, 2022 |
| 4 | Insider transaction | Mar 13, 2023 | Jul 26, 2022 |
| 4 | Insider transaction | Mar 13, 2023 | Dec 5, 2022 |
| 4 | Insider transaction | Mar 13, 2023 | Jul 26, 2022 |
| 3 | Initial insider ownership | Jan 19, 2022 | Sep 27, 2021 |
| 3 | Initial insider ownership | Jan 19, 2022 | Sep 27, 2021 |
| 3 | Initial insider ownership | Jan 19, 2022 | Sep 27, 2021 |
| 3 | Initial insider ownership | Jan 19, 2022 | Sep 27, 2021 |
| 3 | Initial insider ownership | Nov 19, 2021 | Sep 27, 2021 |
| 4 | Insider transaction | Oct 12, 2010 | Sep 30, 2010 |
| 4 | Insider transaction | Oct 12, 2010 | Sep 30, 2010 |
| 3 | Initial insider ownership | Oct 12, 2010 | Sep 30, 2010 |
| 3 | Initial insider ownership | Oct 12, 2010 | Sep 30, 2010 |
| 4 | Insider transaction | Oct 4, 2010 | Aug 23, 2010 |
| 3 | Initial insider ownership | Aug 26, 2010 | Jul 23, 2010 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2010 | — |
| 5 | Annual insider ownership | Feb 16, 2010 | Dec 31, 2009 |
| 4 | Insider transaction | Sep 22, 2009 | Sep 17, 2009 |
| SC 13G | Ownership over 5% (passive) | Feb 20, 2009 | — |
| 4 | Insider transaction | Dec 4, 2008 | Dec 2, 2008 |
| 4 | Insider transaction | Nov 25, 2008 | Nov 4, 2008 |
| 4/A | Primary document | Nov 25, 2008 | Oct 2, 2008 |
| 4 | Insider transaction | Oct 3, 2008 | Sep 30, 2008 |
| 4/A | Primary document | Oct 3, 2008 | Sep 26, 2008 |
| 3/A | Primary document | Oct 3, 2008 | Dec 18, 2007 |
| 4 | Insider transaction | Sep 29, 2008 | Sep 26, 2008 |
| SC 13D | Ownership over 5% (active) | Apr 16, 2008 | — |
| SC 13G | Ownership over 5% (passive) | Mar 19, 2008 | — |
| 3 | Initial insider ownership | Jan 16, 2008 | Dec 18, 2007 |
| 3 | Initial insider ownership | Jan 16, 2008 | Dec 18, 2007 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RAPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1415397
- Former names
- Easy Energy Inc (until May 14, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.